Диссертация (1140300), страница 14
Текст из файла (страница 14)
- 2001 г.. - Apr; 65(4):1146-51.2. Asimakopoulos A.D. Miano R, Virgili G., Finazzi Agrò E. HIFU as salvagefirst - line treatments for palpable,TRUS - evidenced, biopsy-proven locallyrecurrentprostate cancer after radical prostatectomy: pilot study [Статья] // UrolOncol.. - 2012 г.. - Sep;30(5):577-83.3. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy.
Int JRadiat Oncol Biol Phys [Отчет]. - [б.м.] : Mar;37(5):1035-41., 1997.4. Ansari J. Hussain S. A., Zarkar A., et. al. Docetaxel re-treatment for metastatichormone refratory prostate cancer [Статья] // J. Clin. Oncol. - 2008 г..5. Aus G. Current ststus of HIFU and cryotherapy in prostste cancer - a review[Статья] // EUR Urol. - 2006 г.. - Nov 50(5)927-34.6.
Ahmed H.U. Ishaq A., Zacharakis E., Kirkham A. Rectal fistulae after salvagehigh - intensity focused ultrasound for recurrents prostate cancer after: externalbeam radiotherapy and combined brachytherapy. [Статья] // BJU Int. . - 2009г.. - Feb;103(3):321-3.7. Azzouz Н. HIFU: Local Treatment of Prostate Cancer [Статья] // EAU-EBUUpdate Series 4 (2006).
- 2006 г.. - 62-70.8. Blana A. Rogenhofer S., et al. Eight years experience with hogh-intensityfocused ultrasonography for treatment of localized prostate cancer [Статья] //Urology. - 2008 г..9. Beer T.M., Henner W. D. et al. Multiple cycles of intermittent chemotherapy inmetastatic androen-independent prostate cancer [Статья] // Br.
J. Cancer. - 2004г..10.Bolla M Collette L, Blank L, , Mattelaer J, Torecilla JL, Pfeffer JR,Cutajar CL, Zurlo A, Pierart M. Long-term results with immediate androgensuppression and external irradiation in patients with locally advanced prostatecancer. [Статья] // Lancet . - 2002 г.. - Jul;360(9327):103-6..9711.Blana A. Walter B., Wieland WF.
High-intensity focused ultrasound forthe treatment of localized prostate cancer: five-year experience [Статья] //Urology. - 2004 г.. - Feb; 63(2):. - 297-300.12.Boorjian SA Thompson RH, Siddiqui S, et al. Long-term outcome afterradical prostatectomy for patients - with lymphnode positive prostate cancer inthe prostate specific antigen/[Статья] // J Urol . - 2007 г.. - Sep864-70.13.Bott S.R.J.
Management of recurrent disease after radical.' prostatectomy.// Prostate Cancer Prostatic Dis. — 2004. — Vol. 7. — № 3.1. P. 211-216.14.Bolla M Van Poppel H et al. Postoperative radiotherapy after radicalprostatectomy: arandomised controlled trial. [Статья] // Lancet . - 2005 г.. Aug;366:572-8..15.Cadeddu JA Partin AW, DeWeese TL, Walsh PC. Long-term results ofradiation therapy for prostate cancer recurrence following radical prostatectomy[Статья] // J Urol . - 1998 г..
- Jan;159(1):173-7;discussion 177-8..16.Chaussy C., Thuroff S. The status of high-intensity focused ultrasound inthe treatment of localized prostate cancer and the impact of a combined resection.// Curr Urol Rep. — 2003. — Vol. 4. — № 3. — P. 248-252.17.L Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG. Risk ofprostate carcinoma death in patients with lymph node metastasis [Статья] //Cancer . - 2001 г.
91:66-73.18.Carroll P. Rising PSA after a radical treatment. [Статья] // Eur Urol . 2001 г:9-16..19.Castellucci P Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F,Franceschelli A/ Influence of trigger PSAand PSA kinetics on 11CCholine PET /CT detection rate in patients with biochemical relapse after radical-prostatectomy[Статья] // J Nucl Med. - 2009 г.. - Sep;50(9):1394-400.20.Cher ML Bianco FJ Jr, Lam JS, Wood DP Jr. Limited role ofradionuclide bone scintigraphy in patients with prostate antigen specificelevations afterradical prostatectomy [Статья] // J Urol - Oct;160(4):1387-91.21.Cirillo S Petracchini M, Scotti L, Gallo T, Macera A, Bona MC,Ortega C. Endorectal magnetic resonanceimaging at1.5 Tesla to assess localrecurrence following radical prostatectomyusing T2-weighted and contrastenhanced imaging.
[Статья] // Eur Radiol . - 2009 г.. - Mar;19:761-9..9822.Connolly JA Shinohara K. Local recurrence after radical prostatectomy:characteristics in size, location, and relationship to prostate-specific antigen andsurgical margins. [Статья] // Urology . - 1996 г.. - Feb;47(2):225-31..23.Conti PD Atallah AN, Arruda H, Soares BG.
Intermittent versuscontinuous [Статья] // androgen suppression for prostatic cancer. CochraneDatabase Syst. - 2007 г.. - Oct;(4).24.Egewa S Matsumoto K, Suyama K,. Limited suppression of prostatespecific antigen salvage radiotherapy for its isolated elevation after radicalprostatectomy [Статья] // Urology . - 1999 г.. - Jan;53:148-55.25.Fowler JE Jr Brooks J, Variable histology of anastomotic biopsiesdetectable prostate specific antigen after radical prostatectomy [Статья] // J Urol.
- 1995 г.. - Mar;153:1011-4..26.Forman JD Meetze K, Pontes E, Rana T. Therapeutic irradiation forpatients with an elevated postprostatectomy prostate specific antigen level.Статья] // J Urol . - 1997 г.. :1436-9.Foster LS27.Gomez P Manoharan M, at al. Radionuclide bone scintigraphy in patientswith biochemical recurrence after radical prostatectomy. [Статья] // BJU Int . 2004 г.. - Aug;94(3):299-302.28.Gelet A. et al. Local control of prostate cancer by transrectal high intensityfocused ultrasound therapy: preliminary results [Статья] // J. Urol. - 1999 г..29.Haab F Meulemans A, Boccon-Gibbod L, at al.
Effect of radiationtherapy after radical prostatectomy on serum prostate antigen measured by anultrasensitive assay [Статья] // Urology . - 1995 г.. - Jun;45(6):1022-7..30.Haggman M.J., et al. The relationship between prostatic intraepithelialneoplasia and'1 prostate cancer: critical issues. // J Urol. — 1997. — Vol. 158. —№ 1. — P.
12-22.31.Heidenreich A Aus G, Bolla M, Joniau S, et al. EAU guidelines onprostate cancer. [Статья] // Eur Urol. - 2008 г.. - Jan;53:68-80..32.Harding P Moul JW, McLeod DG. Combination flutamide andfinasteride in PSA-only recurrence after prior local prostate cancer therapy[Статья] // J Urol . - 1998 г..
- 159(Suppl):130 (abstr)..Heidenreich A Semrau R, Thüer D, Pfister D. Radical salvageprostatectomy: Treatment of local recurrence of prostate cancer after radiotherapy[Статья] // Urologe A . - 2008 г.. - Nov;47(11):1441-6..33.9934.Heidenreich A. Bolla M., Joniau S., Mason M. D., Matveev V., MottetN. Рак предстательной железы. Рекомендации ЕАУ [Отчет]. - [б.м.] : РООУ,2010.35.Husarik DB Miralbell R, Dubs M, John H, Giger OT, Gelet A,Cservenyàk T, Hany TF. Evaluation of [(18)F]-choline PET/CT for staging andrestaging of prostate cancer [Статья] // Eur J Nucl Med Mol Imaging.
- 2008 г.. Feb;35(2):253-63.36.Hinkle GH Burgers JK, Neal CE, Texter JH, Kahn D, Williams RD,Maguire R. Multicentre radioimmunoscintigraphic evaluation of patients withprostate carcinoma [Статья] // Cancer . - 1998 г.. - Aug;83(4):739-47..37.C.K. Kim, B.K. Park, H.M. Lee / Prediction of locally recurrent prostatecancer after radiation therapy: incremental value of 3T diffusion-weighted MRI[Text] / / J. Magn. Reson. Imaging. – 2009.
– Vol. 29. – № 2. – P. 391-397.38.Kotzerke J Volkmer BG, Hautmann RE, Reske SN. Carbon-11 acetatepositron emission tomography can detect local recurrence of prostate cancer[Статья] // Eur J Nucl Mol Imaging . - 2002 г.. - Oct;29(10):1380-4..39.Krause BJ Souvatzoglou M, Tuncel M at al. The detection rate of[11C]Choline-PET/CT depends on the serum PSA value in patients withbiochemical recurrence [Статья] // Eur J Nucl Med Mol Imaging.
- 2008 г.. Jan;35(1):18-23.40.Lange PH Ercole CJ, Lightner DJ. The value of serum prostate specificantigen determinations before and after radical prostatectomy. [Статья] // J Urol. - 1989 г.. - Apr;141(4):873-9..41.Levesque PE Nieh PT, Zinman LN, Seldin DW, Libertino JA.Radiolabelled monoclonal antibody indium CYT-356 localizes42.Twardowski P., Quinn D. I. Angiogenesis-targeted therapies in prostatecancer [Статья] // Clin Prostste Cancer. - 2006 г..extraprostatic recurrentcarcinoma after prostatectomy [Статья] // Urology .
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
